[Cannabis Health News] UK Home Office urged to provide clarity for CBD industry
[The Times] CBD makers warn products could be taken off the shelves in legal row
[NutraIngredients] The ACI puts pressure on UK Home Office to set THC limit
[NutraIngredients] CBD alliance to benefit from AI technology
[Nutrition Insight] Regulated cannabis plans in UK and EU backed by Chem ID and other industry bodies
ACI, CMC and Chem ID Join Forces to Ensure Authenticity, Validation, and Quality Assurance for Cannabis Products
In a groundbreaking partnership, the Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have teamed up with Chem ID to revolutionize the UK’s legal cannabis industry’s commitment to product authenticity, validation, and quality assurance. The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) are delighted […]
ACI Tox Data Q&A: Dr Parveen Bhatarah and Dr Paul Duffy
In this video ACI’s scientific and regulatory experts Dr Parveen Bhatarah and Dr Paul Duffy answer questions relating to the CBD toxicology studies the ACI undertook to meet safety concerns held by the Food Standards Agency and Committee on Toxicity. The questions came from companies operating in the UK CBD sector.
[Nutrition Insight] ACI’s novel food application validation set to move CBD from “product to ingredient”
[The Grocer] FSA set to validate thousands of CBD products
Statement: ACI novel foods applications validated by FSA
The Association for the Cannabinoid Industry’s (ACI) novel foods applications (RP126 and RP127) have been validated by the Food Standards Agency (FSA). The ACI has received formal notification from the FSA that both its applications for the authorisation of CBD isolate and distillate ‘fall within the scope of the novel foods regime’ as set out […]
